article · Virology Journal

Slow virologic control but strong immune and metabolic recovery with dolutegravir-anchored therapy in an HIV cohort in Ghana

Mark Appeaning
Christèle Nguepou Tchopba
Evelyn Yayra Bonney
Kirk Elorm Kouffie
Becky Tetteh
Edwin O. Magomere
Gloria Akosua Ansa
Bridget Quist
Alberta Mawulawoe Abotsi
Nana Ama Yeboaa Amoako
Peter K. Quashie

20252 citationsOpen accessKoforidua Technical University

Abstract

This study highlights the significant reduction in viral load and improved immune recovery following ART initiation despite uncontrolled viremia in a subset of participants. This cohort presents an opportunity to study Ghana's local HIV epidemic, including HIV-1 and HIV-2, and impact of ART on disease progression.

Research topics

HIV/AIDS Research and Interventions
HIV Research and Treatment
HIV-related health complications and treatments

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12985-025-02873-w

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.